Rare FDA Warning Letter Shows Spanish Drug Claims no Match for Agency Translators By Alexander Gaffney

, RAC - Published 05 August 2014 A Warning Letter issued this week by the US Food and Drug Administration (FDA) to a marketer of pharmaceutical products is a rare example of FDA cracking down on promotional claims made in Spanish and aimed at an audience outside the continental US. - See more at: http://www.raps.org/focus-online/news.aspx#sthash.RReXX9B5.dpuf